Drugs such as Ozempic and other GLP-1s may interfere with medical scan results
GLP-1 weight loss pill in development Fox News senior medical analyst Dr. Marc Siegel discusses advancements in weight…
New ‘unusual’ side effect of weight-loss drugs becoming more common but has no UK guidance
Weight-loss drugs have soared in popularity – but not without consequenceGLP-1 drugs may interfere with medical imaging, leading…
Drinking soft drinks may fuel depression by altering gut bacteria
Researchers have uncovered a surprising link between everyday soft drink habits and mental health, revealing that even moderate…
Adiposity, mortality, and disease risk: insights from bioimpedance analysis and magnetic resonance imaging | BMC Medicine
Study population UKB is a prospective cohort study of over 500,000 men and women aged 40–69 years at…
Resalis Therapeutics Reports Durable, Fat-Selective Weight
Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on…
Advancing precision medicine to transform obesity prevention and treatment
A new report led by researchers at Pennington Biomedical Research Center underscores the growing potential of precision medicine…
Medical schools to prep doctors as India’s lifestyle disease crisis explodes
New Delhi: India is set to introduce mandatory courses on preventive healthcare, including obesity, cancer, women’s and child…
Visceral fat activity linked to advanced endometrial cancer
High metabolic activity of visceral fat may be associated with more aggressive endometrial cancer, new research presented today…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Novo plans online launch for obesity pill once approved, Bloomberg News reports
(Reuters) -Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms…
Cell messengers signal amyloid plaque buildup in obese individuals
Obesity has long been acknowledged as a risk factor for a wide range of diseases, but a more…